Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Envista Holdings Corporation (NVST:NYSE), powered by AI.
Envista Holdings Corporation is currently trading at $24.19. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Envista Holdings Corporation on Alpha Lenz.
View Envista Holdings Corporation's valuation metrics on Alpha Lenz.
“Envista Holdings Corporation's ROE is 1.6%. Explore profitability and growth together.”
Ask for details →Envista Holdings Corporation is a global leader in developing, manufacturing, and marketing a wide range of dental equipment and technology. Operating primarily within the dental industry, the company serves dental professionals with innovative products and solutions. Envista is particularly well-known for its comprehensive offerings in dental consumables, orthodontic appliances, and imaging equipment, which are essential tools for modern dental practices and laboratories. The corporation plays a crucial role in enhancing dental care quality by providing cutting-edge technology and promoting digital dentistry. Envista supports various sectors within dentistry, including preventive care, implantology, and orthodontics, making it integral to dental health professionals worldwide. With a commitment to research and development, Envista continuously brings advancements to the dental market, fostering improved patient outcomes and efficiency in dental services. As a significant industry player, Envista Holdings Corporation contributes to setting benchmarks for innovation and technology integration in healthcare, positioning itself as a key entity in the global dental market landscape.
“Envista Holdings Corporation's ROE is 1.6%. Explore profitability and growth together.”
Ask for details →Envista Holdings Corporation (ticker: NVST) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 12,300 employees.
The current price is $24.19 with a P/E ratio of -x and P/B of -x.
ROE is 1.56% and operating margin is 8.67%. Annual revenue is $2.7B.